Center for Evidence Synthesis in Health, Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island.
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
JAMA Ophthalmol. 2019 Jul 1;137(7):775-785. doi: 10.1001/jamaophthalmol.2019.1063.
Patient care should be informed by clinical practice guidelines, which in turn should be informed by evidence from reliable systematic reviews. The American Academy of Ophthalmology is updating its Preferred Practice Patterns (PPPs) for the management of the following 6 corneal diseases: bacterial keratitis, blepharitis, conjunctivitis, corneal ectasia, corneal edema and opacification, and dry eye syndrome.
To summarize the reliability of the existing systematic reviews addressing interventions for corneal diseases.
The Cochrane Eyes and Vision US Satellite database.
In this study of published systematic reviews from 1997 to 2017 (median, 2014), the Cochrane Eyes and Vision US Satellite database was searched for systematic reviews evaluating interventions for the management of any corneal disease, combining eyes and vision keywords and controlled vocabulary terms with a validated search filter.
The study classified systematic reviews as reliable when each of the following 5 criteria were met: the systematic review specified eligibility criteria for inclusion of studies, conducted a comprehensive literature search for studies, assessed risk of bias of the individual included studies, used appropriate methods for quantitative syntheses (meta-analysis) (only assessed if meta-analysis was performed), and had conclusions that were supported by the results of the systematic review. They were classified as unreliable if at least 1 criterion was not met.
The proportion of systematic reviews that were reliable and the reasons for unreliability.
This study identified 98 systematic reviews that addressed interventions for 15 corneal diseases. Thirty-three of 98 systematic reviews (34%) were classified as unreliable. The most frequent reasons for unreliability were that the systematic review did not conduct a comprehensive literature search for studies (22 of 33 [67%]), did not assess risk of bias of the individual included studies (13 of 33 [39%]), and did not use appropriate methods for quantitative syntheses (meta-analysis) (12 of 17 systematic reviews that conducted a quantitative synthesis [71%]). Sixty-five of 98 systematic reviews (66%) were classified as reliable. Forty-two of the 65 reliable systematic reviews (65%) addressed corneal diseases relevant to the 2018 American Academy of Ophthalmology PPPs; 33 of these 42 systematic reviews (79%) are cited in the 2018 PPPs.
One in 3 systematic reviews addressing interventions for corneal diseases are unreliable and thus were not used to inform PPP recommendations. Careful adherence by systematic reviewers and journal editors to well-established best practices regarding systematic review conduct and reporting might help make future systematic reviews in eyes and vision more reliable.
患者护理应该以临床实践指南为依据,而临床实践指南又应该以可靠的系统评价中的证据为依据。美国眼科学会正在更新其角膜疾病管理的首选实践模式(PPPs),包括以下 6 种角膜疾病:细菌性角膜炎、睑缘炎、结膜炎、角膜扩张、角膜水肿和混浊以及干眼综合征。
总结现有系统评价评估角膜疾病干预措施的可靠性。
Cochrane Eyes and Vision US Satellite 数据库。
在这项研究中,对 1997 年至 2017 年(中位数,2014 年)发表的系统评价进行了分析,通过眼睛和视力关键词以及受控词汇术语与经过验证的搜索筛选器相结合,在 Cochrane Eyes and Vision US Satellite 数据库中搜索了评估任何角膜疾病管理干预措施的系统评价。
当以下 5 个标准均得到满足时,研究将系统评价归类为可靠:系统评价明确了纳入研究的资格标准,进行了全面的文献检索,评估了纳入研究的偏倚风险,使用了适当的定量综合(荟萃分析)方法(仅在进行荟萃分析时评估),并且结论得到了系统评价结果的支持。如果至少有 1 个标准未得到满足,则将其归类为不可靠。
可靠的系统评价比例以及不可靠的原因。
本研究共确定了 98 项针对 15 种角膜疾病干预措施的系统评价。98 项系统评价中有 33 项(34%)被归类为不可靠。不可靠的最常见原因是系统评价未对研究进行全面的文献检索(33 项中的 22 项[67%]),未评估纳入研究的个体偏倚风险(33 项中的 13 项[39%]),未使用适当的定量综合(荟萃分析)方法(17 项进行定量综合的系统评价中有 12 项[71%])。98 项系统评价中有 65 项(66%)被归类为可靠。65 项可靠的系统评价中有 42 项(65%)涉及与 2018 年美国眼科学会 PPP 相关的角膜疾病;其中 33 项(79%)被纳入 2018 年 PPP。
角膜疾病干预措施的系统评价中,每 3 项中就有 1 项不可靠,因此未被用于为 PPP 建议提供依据。系统评价者和期刊编辑严格遵守系统评价实施和报告方面的既定最佳实践,可能有助于提高未来眼睛和视觉方面的系统评价的可靠性。